Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

This is a prospective study to determine if the adjuvant use of Curcumin improves recurrence-free survival.

Trial Details

NCT ID
NCT02064673
Phase
PHASE3
Sponsor
yair lotan
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Curcumin
  • placebo
Locations (sample)
  • Dallas, Texas, United States|32.78306,-96.80667

Key Eligibility Criteria

  • Status post radical prostatectomy for histologically confirmed adenocarcinoma of the prostate
  • pathologically confirmed T1-T3 disease
  • no sign of lymph node or metastatic disease
  • pT1-pT3pNxMx patients in whom standard NCCN or AUA guidelines would suggest are at low risk for pelvic lymph node or metastatic disease and who wou…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →